Cargando…
Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A
P27A is a novel synthetic malaria vaccine candidate derived from the blood stage Plasmodium falciparum protein Trophozoite Exported Protein 1 (TEX1/PFF0165c). In phase 1a/1b clinical trials in malaria unexposed adults in Switzerland and in malaria pre-exposed adults in Tanzania, P27A formulated with...
Autores principales: | Geiger, Kristina M., Guignard, Daniel, Yang, Che, Bikorimana, Jean-Pierre, Correia, Bruno E., Houard, Sophie, Mkindi, Catherine, Daubenberger, Claudia A., Spertini, François, Corradin, Giampietro, Audran, Régine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076177/ https://www.ncbi.nlm.nih.gov/pubmed/32210975 http://dx.doi.org/10.3389/fimmu.2020.00412 |
Ejemplares similares
-
The Synthetic Plasmodium falciparum Circumsporozoite Peptide PfCS102 as a Malaria Vaccine Candidate: A Randomized Controlled Phase I Trial
por: Audran, Régine, et al.
Publicado: (2009) -
P. falciparum and P. vivax Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine
por: Ayadi, Imen, et al.
Publicado: (2020) -
A Malaria Vaccine That Elicits in Humans Antibodies Able to Kill Plasmodium
falciparum
por: Druilhe, Pierre, et al.
Publicado: (2005) -
Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides
por: Pellaton, Céline, et al.
Publicado: (2013) -
The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes
por: Hill, Danika L., et al.
Publicado: (2019)